who discovered glp-1 agonists Discovery of GLP-1–Based Drugs for the Treatment of Obesity The GLP-1 journey: from discovery

The Wegovy label notes that pancreatitis has been reported and that the drug should be discontinued if pancreatitis is confirmed [3]

Ipamorelin, developed by Novo Nordisk in the late 1990s, represents the third generation by incorporating non-natural amino acids (alpha-aminoisobutyric acid and D-2-naphthylalanine) into a minimized pentapeptide scaffold that was specifically optimized for GHS-R1a selectivity using structure-activity relationship studies

Adipocyte (Fat Cell) Function Studies : Investigating changes in fat breakdown (lipolysis) and fat storage (lipogenesis) in isolated adipose tissue or cultured fat cells, including measurement of glycerol and free fatty acid release as metabolic markers

Its been noted to support fertility 27 in studies examining PCOS, amenorrhea, and endometriosis

Clients appreciate the noticeable improvement in skin texture and overall health, making it a favorite for those seeking a refreshed appearance